During the past decade, National Lung Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Lung Hospital" #1 sponsor was "Boston University" with 1 trials, followed by "F2G Biotech GmbH" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored, "Mylan Pharmaceuticals Inc" with 1 trials sponsored and "Oxford University Clinical Research Unit, Vietnam" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Lung Hospital" #1 collaborator was "Harvard Medical School (HMS and HSDM)" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Centre for Infectious Disease Research in Zambia" with 1 trials as a collaborator, "Christian Medical College, Vellore, India" with 1 trials as a collaborator and "De La Salle Health Sciences Institute, Philippines" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "National Lung Hospital" are "Invasive Fungal Infections" (1 trials), "Metastatic Nonsquamous Non-Small Cell Lung Cancer" (1 trials), "Metastatic Squamous Non-Small Cell Lung Cancer" (1 trials), "NSCLC Stage IV" (1 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "National Lung Hospital" in a lesser frequency.

Most popular intervention types in "National Lung Hospital" are "Drug" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Automated CXR (chest X-ray)" (1 trials), "Bedaquiline" (1 trials), "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials) and "Breath sensor" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Lung Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "National Lung Hospital". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Lung Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Lung Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".